Sleep Medicine Reviews
Volume 7, Issue 4 , Pages 351-365 , August 2003

Ceiling and floor effects in sleep research

  • Shawn D. Youngstedt

      Affiliations

    • Correspondence should be addressed to: Shawn D. Youngstedt, PhD, Department of Psychiatry, 0667, University of California, San Diego, 9500 Gilman Dr. La Jolla, CA 92093-0667. Tel.: 858-534-7347; Fax: 858-534-7347; E-mail: syoungstedt@ucsd.edi

References 

  1. Blumenthal, S, Sleep research and mental and addictive disorders. Wake Up America: A National Sleep Alert. Vol. 2: Working Group Reports, Washington, D.C. U.S. Govt. Printing Office, 1994, 206, 249
  2. Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep. 1995;18:425–432
  3. Stepanski EJ, Perlis ML. Behavioral sleep medicine. An emerging subspecialty in health psychology and sleep medicine. J Psychosom Res. 2000;49:343–347
  4. Perlis ML, Youngstedt SD. The diagnosis of primary insomnia and treatment alternatives. Comp Ther. 2000;26:298–306
  5. Kripke DF, Klauber MR, Wingard DL, Fell RL, Assmus JD, Garfinkel L. Mortality hazard associated with prescription hypnotics. Biol Psychiatry. 1998;43:687–693
  6. Kripke DF. Chronic hypnotic use: Deadly risks, doubtful benefit. Sleep Med Rev. 2000;4:5–20
  7. Chesson AL, Anderson WM, Littner M. Practice parameters for the nonpharmacologic treatment of chronic insomnia. Sleep. 1999;22:1128–1133
  8. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia. JAMA. 1999;281:991–999
  9. McClusky HY, Milby JB, Switzer PK, Williams V, Wooten V. Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. Am J Psychiat. 1991;148:121–126
  10. Wilder J. The “Law of Initial Values”, a neglected biological law and its significance for research and practice. In:  Porges SW,  Coles MGH editor. Psychophysiology. Stroudsberg: Dowden, Hutchinson & Ross; 1976;p. 38–46
  11. Jamieson J. The law of initial values: five factors or two?. Int J Psychophysiol. 1993;14:233–239
  12. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF, Kupfer DJ. Benzodiazepines and zolpidem for chronic insomnia: A meta-analysis of treatment efficacy. JAMA. 1997;278:2170–2177
  13. Youngstedt SD. The exercise-sleep mystery. Int J Sport Psychol. 2000;30:241–255
  14. Adam K, Adamson L, Brezinova V, Hunter WM. Nitrazepam: Lastingly effective but trouble on withdrawal. Br Med J. 1976;1:1558–1560
  15. Ancoli-Israel S, Kripke DF, Zorick F, Roth T. Effects of a single dose of Flurazepam on the sleep of healthy volunteers. Arzneimittel-Forschung (Drug Research). 1984;34:99–100
  16. Bergougnan L, Hippius H, Ruther E. Study on polysomnographic and daytime residual effects after single doses of zolpidem, triazolam, lormetazepam and placebo in healthy volunteers. J Sleep Res. 1992;1:
  17. Billiard M, Besset A, De Lustrac C, Brissaud L, Cadilhac J. Effets de la zopiclone sur le sommeil, la somnolence diurne et les performances nocturnes et diurnes chez le volontaire sain. Neurophysiol Clin. 1989;19:131–143
  18. Blois R, Gaillard JM, Attali P, Coquelin JP. Effect of zolpidem on sleep in healthy subjects: a placebo -controlled trial with polysomnographic recordings. Clin Ther. 1993;15:797–809
  19. Borbely AA, Achermann P. Ultradian dynamics of sleep after a single dose of benzodiazepine hypnotics. Eur J Pharmacol. 1991;195:11–18
  20. Borbely AA, Loepfe M, Mattmann P, Tobler I. Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose. Arzneim-Forsch/Drug Res. 1983;33:1500–1502
  21. Borbely AA, Mattmann P, Loepfe M, Strauch I, Lehmann D. Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum Neurobiol. 1985;4:189–194
  22. Borbely AA, Youmbi-Balderer G, Jaggi-Schwartz K. Zolpidem (10mg and 20mg): hypnotic action and residual effects after a single bedtime dose. In:  Sauvenet JP,  Langer SZ,  Morselli PL editor. Imidazopyridines in Sleep Disorders: A Novel Experimental and Therapeutic Approach. New York: Raven Press; 1988;p. 205–210
  23. Brunner DP, Dijk DJ, Munch M, Borbely AA. Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacol (Berlin). 1991;104:1–5
  24. Cerone G, Cirignotta F, Coccagna G. All-night polygraphic recordings on the hypnotic effects of a new benzodiazepine: flunitrazepam (RO 5-4200, Rohypnol). Eur Neurol. 1974;11:172–179
  25. Cluydts R, De Roeck J, Cosyns P, Lacante P. Antagonizing the effects of experimentally induced sleep disturbance in healthy volunteers by lormetazepam and zolpidem. J Clin Psychopharmacol. 1995;15:132–137
  26. Copinschi G, Akseki E, Moreno-Reyes R. Effects of bedtime administration of zolpidem on circadian and sleep-related hormonal profiles in normal women. Sleep. 1995;18:417–424
  27. Copinschi G, Van Onderbergen A, L-Hermite- Baleriaux M. Effect of short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep- related hormonal profiles in normal men. Sleep. 1990;13:232
  28. Feinberg I, Fein G, Walker JM, Price LJ, Floyd TC, March JD. Flurazepam effects on slow-wave sleep: stage 4 suppressed but number of delta waves constant. Science. 1977;198:847–848
  29. Feinberg I, Fein G, Walker JM, Price LJ, Floyd TC, March JD. Flurazepam effects on sleep EEG. Arch Gen Psychiat. 1979;36:95–102
  30. Gaillard J-M, Blois R. Effect of the benzodiazepine antagonist Ro 15–1788 on flunitrazepam-induced sleep changes. Br J Clin Pharmacol. 1983;15:529–536
  31. Gaillard J-M. Differential effects of Flunitrazepam on human sleep in combination with Flumazenil. Sleep. 1989;12:120–132
  32. Godtlibsen OB, Dreyfus JF. Effect of 7.5mg Zopiclone (27.267 Rp) on Sleep Pattern in Normal Subjects. Waking Sleeping. 1980;4:319–325
  33. Guilleminault C, Silvestri R, Mondini S, Coburn S. Aging and sleep apnea: action of benzodiazepine, acetazolamide, alcohol, and sleep deprivation in a healthy elderly group. J Gerontology. 1984;39:655–661
  34. Hemmeter U, Muller M, Bischof R, Annen B, Holsboer-Trachsler E. Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. Psychopharmacology (Berlin). 2000;147:384–396
  35. Kales A, Kales JD, Scharf MB, Tan TL. Hypnotics and altered sleep-dream patterns II. All night EEG studies of chloral hydrate, flurazepam, and methaqualone. Arch Gen Psychiat. 1970;23:219–225
  36. Kanno O, Sasaki T, Watanabe H. Comparison of the effects of zolpidem and triazolam on nocturnal sleep and sleep latency in the morning: A cross-over study in healthy young volunteers. Prog Neuro-Psychopharmacol Biol Psychiat. 2000;24:897–910
  37. Karacan I, Orr WC, Roth T. Dose-related effects of flurazepam on human sleep-waking patterns. Psychopharmacology (Berlin). 1981;73:332–339
  38. Kim Y, Zhuang H, Tsutsumi M, Okabe A, Kurachi M, Kamikawa Y. Comparison of the effect of zopiclone and brotizolam on sleep EEG by quantitative evaluation in healthy young women. Sleep. 1993;16:655–661
  39. Krieger J, Mangin P, Kurtz D. Effects of midazolam on sleep in normal subjects. Arzneimittelforsch. 1983;33:1000–1002
  40. Lehmann W, Liljenberg B. Effect of temazepam and temazepam-ethanol on Sleep. Eur J Clin Pharmacol. 1981;20:201–205
  41. Lund R, Ruther E, Wober W, Hippius H. Effects of zolpidem (10 and 20mg), lormetazepam, triazolam and placebo on night sleep and residual effects during the day. Imidazopyridines in sleep disorders. 1988;193–203
  42. Mamelak M, Csima A, Price V. The effects of a single night's dosing with triazolam on sleep the following night. J Clin Pharmacol. 1990;30:549–555
  43. Mann K, Bauer H, Hiemke C, Roschke J, Wetzel H, Benkert O. Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion. Eur Neuropsychopharmacol. 1996;6:163–168
  44. Mendelson WB. Effects of flurazepam and zolpidem on the perception of sleep in normal volunteers. Sleep. 1995;18:81–88
  45. Merlotti L, Roehrs T, Koshorek G, Zorick F, Lamphere J, Roth T. The dose effects of zolpidem on the sleep of healthy normals. J Clin Psychopharmacol. 1989;9:9–14
  46. Monti JM, Altier H. Flunitrazepam (Ro 5-4200) and sleep cycle in normal subjects. Psychopharmacologia (Berlin). 1973;32:343–349
  47. Mougin F, Simon-Rigaud ML, Mougin C. Met-enkephalin, β-endorphin and cortisol responses to sub-maximal exercise after sleep disturbances. Eur J Appl Physiol. 1992;64:371–376
  48. Nakajima T, Sasaki T, Nakagome K. Comparison of the effects of zolpidem and zopiclone on nocturnal sleep and sleep latency in the morning. A cross-over study in healthy young volunteers. Life Sci. 2000;67:81–90
  49. Nicholson AN, Pascoe PA. Hypnotic activity of an imidazo-pyridine (zolpidem). Brit J Clin Pharmacol. 1986;21:205–211
  50. Nicholson AN, Stone BM. Hypnotic activity and effects on performance of lormetazepam and camazepam–analogues of temazepam. Br J Clin Pharmacol. 1982;13:433–439
  51. Nicholson AN, Stone BM, Pascoe PA. Hypnotic efficacy in middle age. J Clin Pharmacol. 1982;2:118–121
  52. Nicholson AN, Stone BM. Midazolam:sleep and performance studies in middle age. Br J Clin Pharmacol. 1983;16:115S–119S
  53. Nicholson AN, Stone BM. Imidazobenzodiazepines: sleep and performance studies in humans. J Clin Psychopharmacology. 1983;3:72–75
  54. Ogura C, Nakazawa K, Majima K. Residual effects of hypnotics: triazolam, flurazepam, and nitrazepam. Psychopharmacol (Berlin). 1980;68:61–65
  55. Parrino L, Boselli M, Spaggiari MC, Smerieri A, Terzano MG. Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern. Clin Neuropharmacol. 1997;20:253–263
  56. Roehrs T, Kribbs N, Zorick F, Roth T. Hypnotic residual effects of benzodiazepines with repeated administration. Sleep. 1986;9:309–316
  57. Roth T, Kramer M, Schwartz JL. Triazolam: a sleep laboratory study of a benzodiazepine hypnotic. Curr Ther Res. 1974;16:117–123
  58. Roth T, Piccione P, Salis P, Kramer M, Kaffeman M. Effects of temazepam, flurazepam and quinalbarbitone on sleep: psychomotor and cognitive function. Br J Clin Pharmacol. 1979;8:47S–54S
  59. Roth T, Hartse KM, Saab PG, Piccione PM, Kramer M. The effects of flurazepam, lorazepam, and triazolam on sleep and memory. Psychopharmacol (Berlin). 1980;70:231–237
  60. Scharf MB, Mayleben DW, Kaffeman M, Krall R, Ochs R. Dose response effects of zolpidem in normal geriatric subjects. J Clin Psychiatry. 1991;52:77–83
  61. Stone BM, Turner C, Mills SL, Nicholson AN. Hypnotic activity of melatonin. Sleep. 2000;23:663–669
  62. Terzano MG, Parrino L. Evaluation of EEG cyclic alternating pattern during sleep in insomniacs and controls under placebo and acute treatment with zolpidem. Sleep. 1992;15:64–70
  63. Vela-Bueno A, Oliveros JC, Dobladez-Blanco B, Arrigain-Ijurra S, Soldatos CR, Kales A. Brotizolam: a sleep laboratory evaluation. Eur J Clin Pharmacol. 1983;25:53–56
  64. Wright NA, Belyavin A, Borland RG, Nicholson AN. Modulation of delta activity by hypnotics in middle-aged subjects: studies with a benzodiazepine (flurazepam) and a cyclopyrrolone (zopiclone). Sleep. 1986;9:348–352
  65. Yamadera H, Kato M, Tsukahara Y, Kajimura N, Okuma T. Relationship between the effects of a hypnotic drug, zopiclone, on polysomnography and on daytime EEGs. Neuropsychobiol. 1997;35:152–155
  66. Adam K, Oswald I, Shapiro C. Effects of loprazolam and of triazolam on sleep and overnight urinary cortisol. Psychopharmacol (Berlin). 1984;82:389–394
  67. Beary MD, Lacey JH, Crutchfield MB, Bhat AV. Psycho-social stress, insomnia and temazepam: a sleep laboratory evaluation in a “general practice” sample. Psychopharmacol (Berlin). 1984;83:17–19
  68. Benoit O, Bouard G, Payan C, Borderies P, Prado J. Effect of a single dose (10mg) of zolpidem on visual and spectral analysis of sleep in young poor sleepers. Psychopharmacol (Berlin). 1994;116:297–303
  69. Bixler EO, Kales A, Soldatos CR, Kales JD. Flunitrazepam, and investigational hypnotic drug: sleep laboratory evaluations. J Clin Pharmacol. 1977;17:569–578
  70. Bixler EO, Kales A, Soldatos CR, Scharf MB, Kales JD. Effectiveness of temazepam with short-, intermediate-, and long-term use: sleep laboratory evaluation. J Clin Pharmacol. 1978;18:110–118
  71. Bliwise D, Seidel W, Karacan I. Daytime sleepiness as a criterion in hypnotic medication trials: comparison of triazolam and flurazepam. Sleep. 1983;6:156–163
  72. Bliwise DL, Seidel W, Greenblatt DJ, Dement WC. Nighttime and daytime efficacy of flurazepam and oxazepam in chronic insomnia. Am J Psychiat. 1984;141:191–195
  73. Cuanang JR, Limos L. Treatment of insomnia with temazepam: Double-blind, placebo-controlled evaluation. Clin Ther. 1982;4:402–411
  74. Declerck AC, Ruwe F, O'Hanlon JF, Wauquier A. Effects of zolpidem and flunitrazepam on nocturnal sleep of women subjectively complaining of insomnia. Psychopharmacology (Berlin). 1992;106:497–501
  75. Dement WC, Zarcone VP, Hoddes E, Smythe H, Carskadon M. Sleep laboratory and clinical studies with flurazepam. In:  Garattini S,  Mussini E,  Randall LO editor. The Benzodiazepines. New York: Raven Press; 1973;
  76. Dujardin K, Guieu JD, Leconte-Lambert C, Leconte P, Borderies P, De La Giclais B. Comparison of the effects of zolpidem and flunitrazepam on sleep structure and daytime cognitive functions. Pharmacopsychiat. 1998;31:14–18
  77. Fernandez-Guardiola A, Jurado JL, Solis H. The effect of triazolam on insomniac patients using a laboratory sleep evaluation. Curr Ther Res. 1981;29:950–958
  78. Fleming JAE. A sleep laboratory evaluation of the long-term efficacy of zopiclone. Can J Psychiatry. 1988;33:103–107
  79. Frost JD, DeLucchi MR. Insomnia in the elderly: treatment with flurazepam hydrochloride. J Am Geriatr Soc. 1979;27:541–546
  80. Hauri P, Roth T, Sateia MJ, Zorick F. Sleep laboratory and performance evaluation of midazolam in insomniacs. Br J Clin Pharmacol. 1983;16:109S–114S
  81. Herrmann WM, Kubicki ST, Boden S, Eich FX, Attali P, Coquelin J-P. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic ‘learned’ insomnia: psychometric and polysomnographic evaluation. J Int Med Res. 1993;21:306–322
  82. Johnson, LC, Mitler, MM, Dement, WC, Comparative hypnotic effects of flurazepam, triazolam, and placebo: a reanalysis. Naval Health Research Center Report No. 84–13, Bethesda, MD, Naval Medical Research and Development Command, 1984, 1, 25
  83. Jovanovic UJ. Polygraphic sleep recordings before and after the administration of flunitrazepam. J Int Med Res. 1977;5:77–84
  84. Jovanovic UJ, Dreyfus JF. Polygraphical sleep recordings in insomniac patients under zopiclone and nitrazepam. Pharmacol. 1983;27:136–145
  85. Kales A, Allen C, Scharf MB, Kales JD. Hypnotic drugs and their effectiveness. All-night EEG studies of insomniac subjects. Arch Gen Psychiatry. 1970;23:226–232
  86. Kales J, Kales A, Bixler EO, Slye ES. Effects of placebo and flurazepam on sleep patterns in insomniac subjects. Clin Pharmacol Therapeut. 1971;12:691–697
  87. Kales, A, Shart, MB, Sleep laboratory and clinical studies of the effects of benzodiazepines on sleep: flurazepam, diazepam, chlordiazepoxide, and RO 5-4200, Garattini, SMussini, ERandall, LO, The Benzodiazepines, New York, Raven Press, 1973, 577, 598
  88. Kales A, Kales JD, Bixler EO, Scharf MB. Effectiveness of hypnotic drugs with prolonged use: flurazepam and pentobarbital. Clin Pharmacol Ther. 1975;18:356–363
  89. Kales A, Bixler EO, Scharf M, Kales JD. Sleep laboratory studies of flurazepam: a model for evaluating hypnotic drugs. Clin Pharmacol Therapeut. 1976;19:576–583
  90. Kales A, Kales JD, Bixler EO, Scharf MB, Russek E. Hypnotic efficacy of triazolam: sleep laboratory evaluation of intermediate-term effectiveness. J Clin Pharmacol. 1976;399–406
  91. Kales A, Bixler EO, Kales JD, Scharf MB. Comparative effectiveness of nine hypnotic drugs: sleep laboratory studies. J Clin Pharmacol. 1977;17:207–213
  92. Kales A, Scharf MB, Soldatos CR, Bixler EO, Bianchi SB, Schweitzer PK. Quazepam, a new benzodiazepine hypnotic. J Clin Pharmacol. 1980;20:184–192
  93. Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby J, Kales JD. Quazepam and flurazepam: long-term use and extended withdrawal. Clin Pharmacol Ther. 1982;32:781–788
  94. Kales A, Bixler EO, Soldatos CR, Mitsky DJ, Kales JD. Dose-response studies of lormetazepam: efficacy, side effects, and rebound insomnia. J Clin Pharmacol. 1982;22:520–530
  95. Kales A, Soldatos CR, Bixler EO, Goff PJ, Vela-Bueno A. Midazolam: dose-response studies of effectiveness and rebound insomnia. Pharmacology. 1983;26:138–149
  96. Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby JA, Kales JD. Quazepam and temazepam: effects of short- and intermediate-term use an withdrawal. Clin Pharmacol Ther. 1986;39:345–352
  97. Kales A, Bixler EO, Vela-Bueno A, Soldatos CR, Niklaus DE, Manfredi RL. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam. Clin Pharmacol Ther. 1986;40:378–386
  98. Kales A, Manfredi RL, Vgontzas AN, Bixler EO, Vela-Bueno A, Fee EC. Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. Clin Pharmacol Ther. 1991;49:468–476
  99. Kripke DF, Haur P, Ancoli-Israel S, Roth T. Sleep evaluation in chronic insomniacs during a 14-day use of flurazepam and midazolam. J Clin Psychopharmacol. 1990;10:32S–43S
  100. Kryger MH, Steljes D, Pouliot Z, Neufeld H, Odynski T. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem. Sleep. 1991;14:399–407
  101. Mamelak M, Csima A, Price V. A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on chronic insomniacs. J Clin Pharmacol. 1984;24:65–75
  102. Mamelak M, Scima A, Price V. Effects of zopiclone on the sleep of chronic insomniacs. Pharmacol. 1983;27:156–164
  103. McClure DJ, Walsh J, Chang H, Olah A, Wilson R, Pecknold JC. Comparison of lorazepam and flurazepam as hypnotic agents in chronic insomniacs. J Clin Pharmacol. 1988;28:52–63
  104. Mendelson WB, Weingartner H, Greenblatt DJ, Garnett D, Gillin JC. A clinical study of flurazepam. Sleep. 1982;5:350–360
  105. Mitler MM, Carskadon MA, Phillips RL. Hypnotic efficacy of temazepam: a long-term sleep laboratory evaluation. Br J Clin Pharmacol. 1979;8:63S–68S
  106. Mitler MM, Seidel WF, van den Hoed J, Greenblatt DJ, Dement WC. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study. J Clin Psychopharmacol. 1984;4:2–15
  107. Monti JM, Trenchi HM, Morales F, Monti L. Flunitrazepam (Ro 5-4200) and sleep cycle in insomniac patients. Psychopharmacologia (Berlin). 1974;35:371–379
  108. Monti JM, Debellis J, Gratadoux E, Alterwain P, Altier H, D'Angelo L. Sleep laboratory study of the effects of midazolam in insomniac patients. Eur J Clin Pharmacol. 1982;21:479–484
  109. Monti JM. Effect of zolpidem on sleep in insomniac patients. Eur J Clin Pharmacol. 1989;36:461–466
  110. Monti JM, Attali P, Monti D, Zipfel A, De La Giclais B, Morselli PL. Zolpidem and rebound insomnia – A double-blind, controlled polysomnographic study in chronic insomniac patients. Pharmacopsychiat. 1994;27:166–175
  111. Mouret J, Ruel D, Maillard F, Bianchi M. Zopiclone versus triazolam in insomnia geriatric patients: a specific increase in Delta sleep with zopiclone. Int Clin Psycholpharmacol. 1990;5:47–55
  112. Pecknold J, Wilson R, Le Morvan P. Long term efficacy and withdrawal of zopiclone: a sleep laboratory study. Int Clin Psycholpharmacol. 1990;5:57–67
  113. Pegram V, Hyde P, Linton P. Chronic use of triazolam: the effects on the sleep patterns of insomniacs. J Int Med Res. 2001;8:224–231
  114. Quadens OP, Hoffman G, Buytaert G. Effects of zopiclone as compared to flurazepam on sleep in women over 40 years of age. Pharmacology. 1983;27:146–155
  115. Roehrs T, Zorick F, Kaffeman M, Sicklesteel J. Flurazepam for short-term treatment of complaints of insomnia. J Clin Pharmacol. 1982;22:290–296
  116. Roehrs T, Zorick F, Lord N, Koshorek GL, Roth T. Dose-related effects of estazolam on sleep of patients with insomnia. J Clin Psychopharmacol. 1983;3:152–156
  117. Roehrs T, Lamphere J, Paxton C, Wittig R, Zorick F, Roth T. Temazepam's efficacy in patients with sleep onset insomnia. Br J Clin Pharmacol. 1984;17:691–696
  118. Roth T, Kramer M, Lutz T. Intermediate use of triazolam: a sleep laboratory study. J Int Med Res. 1976;4:59–63
  119. Roth T, Zorick F, Sicklesteel J, Stepanski E. Effects of benzodiazepines on sleep and wakefulness. Br J Clin Pharmacol. 1981;11:31S–35S
  120. Sakamoto T, Uchimura N, Mukai M, Mizuma H, Shirakawa S-I, Nakazawa Y. Efficacy of L-846 in patients with insomnia: evaluation by polysomnography. Psychiatr Clin Neurosci. 1998;52:156–157
  121. Saletu B, Anderer P, Brandstatter N. Insomnia in generalized anxiety disorder: Polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (Quazepam versus Triazolam). Neuropsychobiol. 1994;29:69–90
  122. Saletu-Zyhlarz G, Anderer P, Brandstatter N. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder. Neuropsychobiol. 2000;41:139–148
  123. Scharf MB, Bixler EO, Kales A, Soldatos CR. Long-term sleep laboratory evaluation of flunitrazepam. Pharmacol. 1979;19:173–181
  124. Scharf MB, Kales A, Bixler EO, Jacoby JA, Schweitzer PK. Lorazepam – efficacy, side effects, and rebound phenomena. Clin Pharmacol Ther. 1982;31:175–179
  125. Scharf MB, Denson DD, Thompson GA, Goff PJ. Carryover hypnotic effectiveness of diazepam. Curr Ther Res. 1985;37:309–317
  126. Scharf MB, Sachais BA, Mayleben DW, Fletcher K, Jennings SW. A polysomnographic comparison of temazepam 15 and 30mg with triazolam 0.125 and 0.25mg in chronic insomnia. Curr Ther Res. 1990;48:555–567
  127. Scharf MB, Roth T, Vogel GW, Walsh JK. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiat. 1994;55:192–199
  128. Spinweber CL, Johnson LC. Effects of triazolam (0.5mg) on sleep, performance, memory, and arousal threshold. Psychopharmacol (Berlin). 1982;76:5–12
  129. Vgontzas AN, Kales A, Bixler EO, Myers DC. Temazepam 7.5mg: effects on sleep in elderly insomniacs. Eur J Clin Pharmacol. 1994;46:209–213
  130. Vogel G, Thurmond A, Gibbons P, Edwards K, Sloan KB, Sexton K. The effect of triazolam on the sleep of insomniacs. Psychopharmacolgia. 1975;41:65–69
  131. Vogel GW, Barker K, Gibbons P, Thurmond A. A comparison of the effects of flurazepam 30mg and triazolam 0.5mg on the sleep of insomniacs. Psychopharmacol (Berlin). 1976;47:81–86
  132. Walsh JK, Schweitzer PK, Parwatikar S. Effects of lorazepam and its withdrawal on sleep, performance, and subjective state. Clin Pharmacol Ther. 1983;34:496–500
  133. Walsh JK, Fry J, Erwin CW, Scharf M, Roth T, Vogel GW. Efficacy and tolerability of 14-day administration of Zaleplon 5mg and 10mg for the treatment of primary insomnia. Clin Drug Invest. 1998;16:347–354
  134. Walsh JK, Fry J, Richardson GS, Scharf MB, Vogel GW. Short-term efficacy of zaleplon in older patients with chronic insomnia. Clin Drug Invest. 2000;20:143–149
  135. Ware JC, Walsh JK, Scharf MB, Roehrs T, Roth T, Vogel GW. Minimal rebound insomnia after treatment with 10-mg Zolpidem. Clin Neuropharmacol. 1997;20:116–125
  136. Adamson L, Hunter WM, Ogunremi OO, Oswald I, Percy-Robb IW. Growth hormone increase during sleep after daytime exercise. J Endocrinol. 1974;62:473–478
  137. Baekeland F. Exercise deprivation. Sleep and psychological reactions. Arch Gen Psychiatry. 1970;22:365–369
  138. Baekeland F, Lasky R. Exercise and sleep patterns in college athletes. Percept Mot Skills. 1996;23:1203–1207
  139. Bevier WC, Bliwise DL, Bliwise NG, Bunnell DE, Horvath SM. Sleep patterns of older adults and the effects of exercise. J Clin Exper Gerontol. 1992;14:1–15
  140. Bonnet MH. Sleep, performance and mood after the energy-expenditure equivalent of 40 hours of sleep deprivation. Psychophysiol. 1980;17:56–63
  141. Browman CP. Sleep following sustained exercise. Psychophysiol. 1980;17:577–580
  142. Browman CP, Tepas DI. The effects of pre-sleep activity on all-night sleep. Psychophysiol. 1976;13:536–540
  143. Buguet A, Roussel R, Angus R, Sabiston B, Randomski M. Human sleep and adrenal individual reactions to exercise. Electroencephalogr Clin Neurophysiol. 1980;49:515–523
  144. Bunnell DE, Bevier WC, Horvath SM. Effects of exhaustive exercise on the sleep of men and women. Psychophysiol. 1983;20:50–58
  145. Bunnell DE, Bevier WC, Horvath SM. Nocturnal sleep, cardiovascular function, and adrenal activity following maximum-capacity exercise. Electroencephalogr Clin Neurophysiol. 1983;56:186–189
  146. Desjardins J, Healey T, Broughton RJ. Early evening exercise and sleep. Sleep Res. 1974;3:31
  147. Driver HS, Meintjes AF, Rogers GG, Shapiro CM. Submaximal exercise effects on sleep patterns in young women before and after an exercise training program. Acta Physiol Scand. 1988;33:8–13
  148. Driver HS, Rogers GG, Mitchell D. Prolonged endurance exercise and sleep disruption. Med Sci Sports Exerc. 1994;26:903–907
  149. Griffin SJ, Trinder J. Physical fitness, exercise, and human sleep. Psychophysiol. 1978;15:447–450
  150. Hauri P. The influence of evening activity on the onset of sleep. Psychophysiol. 1969;5:426–430
  151. Horne JA, Moore VJ. Sleep EEG effects of exercise with and without additional body cooling. Electroencephalogr Clinl Neurophysiol. 1985;60:33–38
  152. Horne JA, Porter JM. Time of day effects with standardized exercise upon subsequent sleep. Electroencephalogr Clin Neurophysiol. 1976;40:178–184
  153. Horne JA, Staff LHE. Exercise and sleep: body-heating effects. Sleep. 1983;6:36–46
  154. Matsumoto K, Saito Y, Abe M, Furmi K. The effects of daytime exercise on night sleep. J Hum Ergol. 1984;13:31–36
  155. Montgomery I, Trinder J, Paxton S. Energy expenditure and total sleep: effect of physical exercise. Sleep. 1982;5:159–168
  156. Montgomery IJ, Trinder J, Paxton S, Fraser G. Sleep disturbance following a marathon. J Sports Med Phys Fitness. 1985;25:69–74
  157. Montgomery IJ, Trinder J, Paxton S, Fraser G. Aerobic fitness and exercise: effects on the sleep of younger and older adults. Aust J of Psychol. 1987;39:259–272
  158. Montgomery IJ, Trinder J, Paxton S, Harris D, Fraser G, Colrain I. Physical exercise and sleep: the effects of the age and sex of the subjects and type of exercise. Acat Physiolog Scand. 1988;133:36–40
  159. Montmayeur A, Buguet A, Sollin H, Lacour JR. Exercise and sleep in four African sportsmen living in the Sahel. Int J Sports Med. 1994;15:42–45
  160. Naylor E, Penev PD, Orbeta L. Daily social and physical activity increases slow-wave sleep and daytime neuropsychological performance in the elderly. Sleep. 2000;23:87–95
  161. Paxton SJ, Montgomery I, Trinder J, Newman J, Bowling A. Sleep after exercise of variable intensity in fit and unfit subjects. Aust J Psychol. 1982;34:289–296
  162. Shapiro CM, Bortz R, Mitchell D, Bartel P, Jooste P. Slow-wave sleep: a recovery period after exercise. Science. 1981;214:1253–1254
  163. Shapiro CM, Bortz R, Mitchell D, Clarke RAI, Jooste PL. Effect of exercise in a hot environment on human sleep patterns. Suid-Afrikaanse Tydskrif vir Wetenskap. 1985;81:624–627
  164. Torsvall L, Akerstedt T, Lindbeck G. Effects on sleep stages and EEG power density of different degrees of exercise in fit subjects. Electroencephalogr Clin Neurophysiol. 1984;57:347–353
  165. Vein AM, Sidorov AA, Murtazaev MS, Kaarlov AV, Fedorenko VN. Physical exercise and nocturnal sleep in healthy humans. Hum Physiol. 1991;17:391–397
  166. Walker JM, Floyd TC, Fein G, Cavness C, Lualhati R, Feinberg I. Effects of exercise on sleep. J Appl Physiol. 1978;44:945–951
  167. Youngstedt SD, O'Connor PJ, Crabbe JB, Dishman RK. The influence of acute exercise on sleep following high caffeine intake. Physiol Behav. 2000;68:563–570
  168. Zir LM, Smith RA, Parker DC. Human growth hormone release in sleep: effect of daytime exercise. J Clin Endocrinol Metab. 1971;32:662–665
  169. Benjamin LS. Facts and artifacts in using analysis of covariance to “undo” the law of initial values. Psychophysiol. 1967;4:187–202
  170. Jean-Louis G, Kripke DF, Ancoli-Israel S, Klauber MR, Sepulveda RS. Sleep duration, illumination, and activity patterns in a population sample: effects of gender and ethnicity. Biol Psychiat. 2000;47:921–927
  171. Youngstedt SD, O'Connor PJ, Dishman RK. The effects of acute exercise on sleep: a quantitative synthesis. Sleep. 1997;20:203–214
  172. Carskadon MA, Dement WC, Mitler MM, Guilleminault C, Zarcone VP, Spiegel R. Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiat. 1976;133:1382–1388
  173. Edinger JD, Fins AI, Glenn DM. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints?. J Consult Clin Psychol. 2000;68:586–593
  174. Erman MK, Mendelson WB, Roehrs TA, Roth T, Walsh JK. The Pharmacological Management of Sleep. Washington: National Sleep Foundation; 1996;
  175. King AC, Oman RF, Brassington GS, Bliwise DL, Haskell WL. Moderate-intensity exercise and self-rated quality of sleep in older adults. A randomized controlled trial. JAMA. 1997;277:32–37

PII: S1087-0792(01)90239-4

doi: 10.1053/smrv.2001.0239

Sleep Medicine Reviews
Volume 7, Issue 4 , Pages 351-365 , August 2003

Article Tools